Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention

OBJECTIVE: To estimate the incidence of major adverse cardiovascular events (MACE) with genotype test-guided antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome. METHODS: Patients who had undergone PCI for acute coronary syndrome as well a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, S., Socrates, S., Rajasekaran, M.A., Senguttuvan, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772580/
https://www.ncbi.nlm.nih.gov/pubmed/33357650
http://dx.doi.org/10.1016/j.ihj.2020.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772580/
https://www.ncbi.nlm.nih.gov/pubmed/33357650
http://dx.doi.org/10.1016/j.ihj.2020.09.002

Ejemplares similares